I agree - this is another puzzling and troublesome part of Section 21. Why should any competitor be prevented from publishing the results of their work? The rights exclusively granted to HPN include, "... publicly perform, publicly display, digitally perform", and the "Licensed Materials" include the predictive algorithm. Even if you use a completely different data set, they still control virtually all of the rights to your work, including the right to publish.
I plan to bring this up with Dr. Merkin, in addition to the ownership / IP issues.